Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06666842 · ClinicalTrials.gov registry record · NA
Longitudinal Effects of a Commercial Digital Weight Management Program on Weight Loss
A NA study, sponsored by Noom.
- Completed
- Registry status
- NA
- Development phase
- 412
- Enrollment target
NCT06666842: Completed NA study, sponsored by Noom.
NCT06666842 is a NA study that has completed, run by Noom. The registered enrollment target is 412 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (71% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06666842, a NA study, has completed, sponsored by Noom.
- COMPLETED
- Registry status
- NA
- Development phase
- 412 participants
- Enrollment target
Study Summary
This randomized controlled trial (RCT) will test how well a fully remote weight management program (Noom Weight) helps adults with overweight or obesity (BMI 25-45) achieve weight loss in both the short-term (16 weeks) and the long-term (68 weeks), compared to an educational program). Participants will be randomly assigned to use the 16-week Noom Weight program or receive weekly emails with weight loss-related tips and information. Weight will be measured at baseline, 16, 29, 42, and 68 weeks. Changes in physical activity, eating disorder risk, and body appreciation will also be assessed.
Primary Outcome
Body weight will be measured using self-report and cellular-connected digital scales (Body Trace). The digital scale is linked to participant IDs and synced to record weigh-ins automatically. If a participant does not report a weight or the reported weight appears to be erroneous, then the raw scale data will be used.
Interventions
- BEHAVIORAL Educational Control
- BEHAVIORAL Noom Weight
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 412 participants |
| Start Date | 2022-06-01 |
| Est. Completion | 2023-12-01 |
| Phase | NA |
What the finished NCT06666842 record still lists
NCT06666842 is an interventional study that assigns participants to a tested intervention. The registered 412 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (71% lower).
The record links to 0 conditions, and to 2 interventions - of which Educational Control is the first listed.
NCT06666842 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06666842 about?
NCT06666842 is a clinical study titled "Longitudinal Effects of a Commercial Digital Weight Management Program on Weight Loss". This randomized controlled trial (RCT) will test how well a fully remote weight management program (Noom Weight) helps adults with overweight or obesity (BMI 25-45) achieve weight loss in both the short-term (16 weeks) and the long-term (68 weeks), compared to an educational program). Participants w...
What is the current status of trial NCT06666842?
This trial is currently completed. It is a NA study. The enrollment target is 412 participants. The study started on 2022-06-01. Estimated completion is 2023-12-01.
What interventions are being tested in trial NCT06666842?
The interventions under investigation include: Educational Control (BEHAVIORAL), Noom Weight (BEHAVIORAL).
Who is sponsoring clinical trial NCT06666842?
This trial is sponsored by Noom, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06666842's enrollment target sits among peer trials
412 241st of 2000 higher than 1,759 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05993689 · 412 participants · NA
Building TrUst and UNiting Teams Through DouLa partnErship - BUNDLE
- NCT06699212 · 412 participants · Phase 3
A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases
- NCT03592472 · 413 participants · Phase 3
A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)
- NCT06697197 · 413 participants · Phase 1
A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI